Home/Filings/4/0000905148-24-002307
4//SEC Filing

Sullivan Adam Taylor 4

Accession 0000905148-24-002307

CIK 0001839341other

Filed

Aug 19, 8:00 PM ET

Accepted

Aug 20, 7:44 PM ET

Size

7.4 KB

Accession

0000905148-24-002307

Insider Transaction Report

Form 4
Period: 2024-08-16
Sullivan Adam Taylor
DirectorChief Executive Officer
Transactions
  • Exercise of In-Money

    Common Stock

    2024-08-16$0.01/sh+95,303$9534,057,579 total
  • Exercise of In-Money

    Tranche 2 Warrants

    2024-08-1695,3030 total
    Exercise: $0.01Exp: 2029-01-23Common Stock (95,303 underlying)
Footnotes (2)
  • [F1]The Reporting Person received 95,303 Tranche 2 Warrants on April 3, 2024 for no consideration in connection with an in-kind distribution by XMS Capital Partners, LLC, which acquisition was exempt from Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16a-9 under the Exchange Act.
  • [F2]Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of the Issuer's common stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days, subject to certain adjustments. The Tranche 2 Warrants became exercisable at the option of the registered holders on July 11, 2024.

Documents

1 file

Issuer

Core Scientific, Inc./tx

CIK 0001839341

Entity typeother

Related Parties

1
  • filerCIK 0001980208

Filing Metadata

Form type
4
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 7:44 PM ET
Size
7.4 KB